Meet Our Team
Medical Oncology
Glenn Bubley, MD is a renowned expert in genitourinary (GU) medical oncology with a primary focus on prostate cancer. He serves as Director of Genitourinary Oncology at BIDMC and is Associate Professor of Medicine at Harvard Medical School. As Director of the multidisciplinary genitourinary cancer program at BIDMC involving medical, surgical and radiation oncologists as well as pathologists and basic scientists, he heads numerous clinical/translational trials. Dr. Bubley has authored numerous scientific, research and translation papers and articles in his area of expertise, prostate cancer.
Board certified in Internal Medicine and Medical Oncology, he earned his medical degree from Michigan State University College of Human Medicine, completed a residency at Saint Francis Hospital and Medical Center in Medicine and a Fellowship at Beth Israel Deaconess Medical Center in Hematology/Oncology. Dr. Bubley is an Associate Professor of Medicine, Harvard Medical School. In addition, he is Co-Principal Investigator for the prestigious Prostate SPORE (Specialized Programs of Research Excellence) at the Dana Farber/Harvard Cancer Center which is a pilot study for the development of an anti-prostate cancer agent. He oversees the Hershey Family Prostate Cancer Tissue Bank and Data base and directs interventional research for GU oncology as well, overseeing trials for patients with prostate or bladder cancer.
Marc B. Garnick, MD is an internationally renowned expert in medical oncology and urologic cancer has dedicated his career to helping his patients and their families understand the complex medical issues when faced with determining appropriate treatment choices and the development of new therapies for the treatment of prostate cancer.To further research in prostate cancer, Dr. Garnick founded the Hershey Family Foundation for Prostate Cancer Research. He serves as Editor-in-Chief of Harvard Medical School's Annual Report on Prostate Diseases and its associated website HarvardProstateKnowledge.org and has authored numerous scientific articles and books including A Patient's Guide to Prostate Cancer, reviews on clinical research, drug development, and cancer biology.
Board certified in Internal Medicine and Medical Oncology, he earned his medical degree from the University of Pennsylvania School of Medicine, completed his internship and residency at the Hospital of the University of Pennsylvania and Fellowhsips at National Institute of Child Human Health & Development in Oncology and Dana-Farber Cancer Institute in Oncology. Dr. Garnick is Clinical Professor of Medicine at Harvard Medical School. In addition, he serves as Director of Community Cancer Services for The Cancer Center and as Executive Director of Physician Initiated Philanthropy.
Rupal Bhatt, MD, PhD, MMS is an attending physician whose clinical and research focuses on patients with renal cell carcinoma, prostate, bladder and testis cancer with a special interest in the Mechanisms of Resistance to Antiangiogenic Therapy. For this work was awarded Young Investigator Awards from AACR and ASCO and was also was awarded the ASCO Career Development Award. Currently She was also received Mentored Clinical Scientist Development Award from the National Cancer Institute designed to train clinicians committed to a career in laboratory or field-based research or to translational research with a laboratory focus.
Board Certified in Internal Medicine and Medical Oncology, she earned her medical and graduate degrees at Weill Medical College of Cornell University Medical College and The Rockefeller University where she received her MD/PhD degrees, completed her Residency, a Fellowship in Hematology/Oncology and began her research all at BIDMC. Dr. Bhatt received her Masters of Medical Science during her participation in the Clinical Investigator Training Program in and is an Assistant Professor of Medicine at Harvard Medical School
Radiation Oncology
Joseph Aronovitz, MD PhD
Irving Kaplan, MD, Co-Director of Prostate Cancer Care Program
Surgical Oncology
William DeWolf, MD, FACS , is Chief of the Division of Urology at Beth Israel Deaconess Medical Center (BIDMC). He is also the chaired BIDMC Professor of Urologic Surgery at Harvard Medical School (HMS). Dr. DeWolf received his undergraduate degree from Northwestern University and his M.D. from the Northwestern's Feinberg School of Medicine. Following a general surgery residency at Rush Presbyterian Saint Luke's Hospital in Chicago, Dr. DeWolf completed additional training in General Surgery Transplantation and Urologic Surgery at the University of Minnesota.
An esteemed surgeon, Dr. DeWolf's clinical interests include urologic malignancies and prostate diseases. He is also Director of the Urologic Research Laboratories at BIDMC. Dr. DeWolf's research focuses on the molecular genetics and biochemistry of prostate and other urologic cancers. He is currently conducting stem cell research to gain a better understanding of how urologic cancers form, and he has made significant progress in this area.
Dr. DeWolf has received several major awards from the National Institutes of Health (NIH), American Urological Association, and, on three separate occasions, the Harvard Program in Urology. He served as President of the National Urologic Forum, and is a member of organizations such as the Society for Basic Urologic Research, American Association for Cancer Research, and American Society of Genitourinary Surgeons. He is on the Editorial Board of Urology, and is a peer reviewer for several other major urologic and scientific journals. Dr. DeWolf has also authored or co-authored more than 200 articles and chapters, which have been published in leading medical journals and in medical textbooks.
Michael Kearney, MD is a urologist whose clinical practice fosuces on stone disease, urologic cancers and benign prostatic hyperplasia.
Board certified in Urology, he earned his medical degree from Boston University School of Medicine, completed an Internship in surgery at Columbia Presbyterian Hospital and a Residency in Urology at Columbia Presbyterian Hospital.
Andrew A.Wagner, MD is Assistant Professor of Surgery at Harvard Medical School and Director of Minimally Invasive Urologic Surgery at BIDMC. He was recruited to the urologic faculty at BIDMC in 2006 to develop and lead the robotic surgery program after completing a fellowship in laparoscopy and robotics at The Brady Institute of Urology at Johns Hopkins University. Dr. Wagner specializes in minimally invasive surgical approaches to urologic cancer, particularly prostate and kidney cancer. His research interests include evaluating health related quality of life in patients following prostate and kidney surgery and discovering new ways to train surgeons in robotics. To this end he has developed a novel surgical simulator for robotic prostatectomy.
Dr. Wagner has authored several textbook chapters and peer reviewed articles describing his robotic prostatectomy technique and has performed hundreds of robotic prostatectomy surgeries. A graduate of the State University of New York at Buffalo School of Medicine, Buffalo, NY; 1998 Dr. Wagner completed his surgical residency at UMass Memorial Medical Center and has received certification by the American Board in Urology.
Pathology
Elizabeth Genega, MD
Seymour Rosen, MD
Huihui Ye, MD
Affiliate Urologists
Joseph Ciccone, MD; Paul Church, MD; William Conners, MD; Nadeem Dhanani, MD; Robert Eyre, MD; Gary Kearney, MD; Stephen Lazarou, MD; Abraham Morgentaler, MD; Kathy Kiknejad, MD; Wilmer Roberts, MD; Brian Saltzman, MD; Ned Saltzman, MD